Ghrelin Receptor (GHS-R1a) Selective Activation Ipamorelin acts as a highly selective agonist of the growth hormone secretagogue receptor (GHS-R1a), mimicking the natural hormone ghrelin without affecting other pituitary hormone secretion: Selective binding to GHS-R1a receptors without stimulating ACTH, cortisol, or prolactin release Rapid onset of growth hormone pulse generation (peak levels within 40-60 minutes) No significant effect on appetite stimulation unlike other ghrelin mimetics Preserved feedback regulation through endogenous growth hormone-releasing inhibitory mechanisms Research indicates that ipamorelin releases growth hormone with potency and efficacy similar to GHRP-6 (EC50 approximately 1.3 nmol/L) but with superior selectivity for growth hormone secretion
Targarona EM, Bendahan G, Balague C, Garriga J, Trias M
10.1155/2014/296053 211 OjhaS.YadavS.AggarwalB.GuptaS
: NAP-03770 NaturesPlus, Hema-Plex, 30 + 26 1690 : LEX-19456 Life Extension, B, 60 + 28 1450 : 1
GHK-Cu activates the Wnt/beta-catenin pathway that drives the anagen (growth) phase of the hair cycle, stimulates VEGF and hepatocyte growth factor for follicle health, and has been shown in clinical research to increase follicle size and density with sustained use
Proven cardiovascular safety from SELECT (20% MACE reductio
